SEC Form 4 · accession 0001307632-15-000002
SCICLONE PHARMACEUTICALS INC · SCLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard J Hawkins
Director
Period of report
May 14, 2015
Accepted (ET)
May 18, 2015 · 7:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000880771
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 14, 2015 | S | 18,727 | $9.1617 | D | 15,682 | D |
Table II — derivative securities
No Table II lines on this filing.